HK1017378A1 - Processes for preparation of marek's disease virus using continuous mammalian cell lines - Google Patents

Processes for preparation of marek's disease virus using continuous mammalian cell lines

Info

Publication number
HK1017378A1
HK1017378A1 HK99102274A HK99102274A HK1017378A1 HK 1017378 A1 HK1017378 A1 HK 1017378A1 HK 99102274 A HK99102274 A HK 99102274A HK 99102274 A HK99102274 A HK 99102274A HK 1017378 A1 HK1017378 A1 HK 1017378A1
Authority
HK
Hong Kong
Prior art keywords
marek
processes
preparation
cell lines
mammalian cell
Prior art date
Application number
HK99102274A
Other languages
English (en)
Inventor
Tracy Michelle Brown
Jay Gregory Calvert
Michael Clayton Deichert
Stephen Wayne May
Kent Michael Mulkey
Michael Kenneth O'hara
Sing Rong
Michael George Sheppard
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1017378A1 publication Critical patent/HK1017378A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK99102274A 1997-06-10 1999-05-24 Processes for preparation of marek's disease virus using continuous mammalian cell lines HK1017378A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4905597P 1997-06-10 1997-06-10

Publications (1)

Publication Number Publication Date
HK1017378A1 true HK1017378A1 (en) 1999-11-19

Family

ID=21957831

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102274A HK1017378A1 (en) 1997-06-10 1999-05-24 Processes for preparation of marek's disease virus using continuous mammalian cell lines

Country Status (11)

Country Link
EP (1) EP0884382A3 (fr)
JP (1) JPH119290A (fr)
CN (1) CN1113097C (fr)
AR (1) AR012944A1 (fr)
AU (1) AU753963B2 (fr)
BR (1) BR9801992A (fr)
CA (1) CA2234423A1 (fr)
HK (1) HK1017378A1 (fr)
NZ (1) NZ330643A (fr)
TW (1) TWI243208B (fr)
ZA (1) ZA984970B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1688335A (zh) * 2002-02-06 2005-10-26 洛曼动物健康两合公司 生产疫苗的连续细胞系
KR101123023B1 (ko) * 2002-10-15 2012-03-15 와이어쓰 엘엘씨 조류 조직 샘플중의 바이러스 검출 분석 방법
CN102114243B (zh) * 2006-08-11 2013-08-28 深圳市孚沃德生物技术有限公司 流行性感冒原代地鼠肾细胞多价疫苗的制备方法
CN107299078B (zh) * 2017-07-27 2020-06-05 郑州爱科生物科技有限公司 一株适应全悬浮培养的猫肾细胞系f-81 s及其应用
CN118028252A (zh) * 2024-04-15 2024-05-14 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 表达ciav vp1和vp2基因的重组鸡马立克病病毒疫苗株及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231023A (en) * 1990-07-30 1993-07-27 Akzo N.V. Recombinant Marek's disease virus
EP0550553B1 (fr) * 1990-09-25 2000-07-12 Cantab Pharmaceuticals Research Limited Vaccin viral mutant a genome deficient et produit en transcomplementant la lignee cellulaire
EP0748867A1 (fr) * 1995-06-12 1996-12-18 Duphar International Research B.V Vaccin contre la maladie de Marek
US5833980A (en) * 1995-10-27 1998-11-10 Board Of Trustess Operating Michigan State University Sustainable cell line for the production of the Marek's disease vaccines

Also Published As

Publication number Publication date
BR9801992A (pt) 2000-01-11
NZ330643A (en) 1999-11-29
EP0884382A2 (fr) 1998-12-16
CN1203275A (zh) 1998-12-30
CN1113097C (zh) 2003-07-02
JPH119290A (ja) 1999-01-19
ZA984970B (en) 1999-12-09
EP0884382A3 (fr) 2000-10-25
CA2234423A1 (fr) 1998-12-10
AU6998298A (en) 1998-12-17
AU753963B2 (en) 2002-10-31
TWI243208B (en) 2005-11-11
AR012944A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
SG113402A1 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
AU2991697A (en) Methods of diagnosing clinical subtypes of crohn's disease
AU8143791A (en) Recombinant marek's disease virus
IL154116A0 (en) Sythesis of intermediates for the preparation of growth hormone secretagogues
PL326604A1 (en) Derivatives of 5"-dezoxy-cytidin
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
HUP9901176A3 (en) Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives and their intermediates
EP0486106A3 (en) Marek's disease virus vaccine
HUP0002159A3 (en) Process for preparing intermediates of pesticidally active compounds, the novel intermediates using in this process and preparation thereof
HK1017378A1 (en) Processes for preparation of marek's disease virus using continuous mammalian cell lines
HUP0003958A3 (en) Process for preparation of 4-aryl-piperidines and intermediates
EP1064947A4 (fr) Vaccination in ovo contre le virus de la maladie de marek, type 1
ZA973696B (en) Processes and intermediates for preparing 4'-trifluoro-methylbiphenyl-2-carboxylic acid [2-(2H-[1,2,4]triazol-3-ylmethyl)-1-2-3-4-tetrahydro-isoquinolin-6-yl]-amide
ZA997114B (en) Processes for preparation of Marek's Disease Virus using continuous avian cell lines.
IL142502A0 (en) Intermediates for the preparation of biologically active benzothiazolone ethanamines
ZA964878B (en) Marek's disease vaccine
IL114501A0 (en) Marek's disease virus vaccine
EP0770677A3 (fr) Lignées cellulaires améliorées stables de poulet pour la production de vaccins contre la maladie de Marek
GB2317800B (en) Angler's weight
HUP0002505A3 (en) Process for the preparation of [2-((8,9)-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid and the intermediates thereof
EG20098A (en) Process for preparing of cell free Marek's disease virus vaccina
AU697814B2 (en) Improvements in sustainable cell line for the production of Marek's disease vaccines
GB9807032D0 (en) Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine
EP0745127A4 (fr) Controle de la maladie de marek par inhibition de la latence et du developpement des cellules tumorales
AU5276196A (en) Method for the continuous preparation of recombinant proteinsfrom cell cultures

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070609